Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
NASDAQ:JYNT
JYNT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.58 - $17.82
Previous CloseN/A
Volume11.07K
Average Volume (3M)87.15K
Market Cap
$150.16M
Enterprise Value$133.55M
Total Cash (Recent Filing)$20.80M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.08
Next Earnings
May 01, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding15,322,532
10 Day Avg. Volume70,882
30 Day Avg. Volume87,152
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.72
Price to Cash Flow (P/CF)11.70
P/FCF Ratio11.70
Enterprise Value/Market Cap0.89
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda44.79
Forecast
1Y Price Target
$15.17Price Target Upside53.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
---
Joint News
PremiumCompany Announcements
The Joint Corp. Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
The Joint Corp. Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Joint Corp. Amends Executive Incentive Plan for 2025
---
Bulls Say, Bears Say
Bulls Say
Business TransitionThe strategic shift is anticipated to result in The Joint becoming an overall more profitable business with an improved margin structure.
Digital StrategyThe Joint is advancing its digital strategy, with increased online scheduling capabilities and the launch of its first mobile app expected, which could improve the patient experience and drive repeat visits.
Financial PositionJYNT had $25.1M in cash and no debt, and it is expected to generate positive cash flows from continuing operations.
Bears Say
Clinic Sale UncertaintyThe exact timeline for the sale of company-owned clinics remains unclear.
Industry ChallengesDespite reporting a slight y/y improvement in 3Q24 revenue and announcing signs of a rebound in patient demand back in July, industry headwinds persisted throughout 3Q24 and are likely to continue.
Market ConditionsThe company lowered 2024 sales and clinic opening guidance, reflecting management's expectation of continued softness in patient demand through 4Q24.
---
Ownership Overview
2.55% Insiders
12.68% Mutual Funds
1.18% Other Institutional Investors
74.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
JYNT FAQ
What was Joint Corp’s price range in the past 12 months?
Joint Corp lowest stock price was $9.58 and its highest was $17.82 in the past 12 months.
What is Joint Corp’s market cap?
Joint Corp’s market cap is $150.16M.
When is Joint Corp’s upcoming earnings report date?
Joint Corp’s upcoming earnings report date is May 01, 2025 which is in 6 days.
How were Joint Corp’s earnings last quarter?
Joint Corp released its earnings results on Mar 13, 2025. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of $0.01 by -$0.19.
Is Joint Corp overvalued?
According to Wall Street analysts Joint Corp’s price is currently Undervalued.
Does Joint Corp pay dividends?
Joint Corp does not currently pay dividends.
What is Joint Corp’s EPS estimate?
Joint Corp’s EPS estimate is <0.01.
How many shares outstanding does Joint Corp have?
Joint Corp has 15,322,532 shares outstanding.
What happened to Joint Corp’s price movement after its last earnings report?
Joint Corp reported an EPS of -$0.18 in its last earnings report, missing expectations of $0.01. Following the earnings report the stock price went up 4.554%.
Which hedge fund is a major shareholder of Joint Corp?
Currently, no hedge funds are holding shares in JYNT
---
Joint Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.17 (53.70% Upside)
$15.17 (53.70% Upside)
Blogger Sentiment
Neutral
JYNT Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 127.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.60%
12-Months-Change
Fundamentals
Return on Equity
-22.63%
Trailing 12-Months
Asset Growth
-7.72%
Trailing 12-Months
Company Description
Joint Corp
Joint (JYNT), known as The Joint Chiropractic, is a healthcare services company focused on providing chiropractic care through a network of clinics across the United States. The company operates in the health and wellness sector, offering a range of services aimed at improving mobility and reducing pain through routine and affordable chiropractic adjustments. The Joint Chiropractic distinguishes itself by providing convenient, no-appointment, and membership-based services, allowing patients to access care at their convenience.
---
JYNT Company Deck
---
JYNT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in new patient growth and revenue increases, alongside strategic progress in refranchising efforts. However, challenges such as decreased franchise license sales, economic headwinds, and the transitional financial impact of refranchising were noted. While the company is making strides towards profitability and growth, it is facing some economic and operational challenges.Read More>---
JYNT Stock 12 Month Forecast
Average Price Target
$15.17
▲(53.70% Upside)
Technical Analysis
Best Analysts Covering JYNT
1 Year
1 Year Success Rate
10/18 ratings generated profit
1 Year Average Return
+116.04%
reiterated a buy rating 9 months ago
Copying Jeff Van Sinderen's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +116.04% per trade.
---